CompletedPhase 3

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

Czechia5,803 participantsStarted 2005-09-01

Plain-language summary

An observer-blind study to evaluate GlaxoSmithKline Biologicals' live attenuated varicella vaccine and GlaxoSmithKline Biologicals' combined measles-mumps-rubella-varicella vaccine in the prevention of varicella disease in children. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

Who can participate

Age range11 Months – 22 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. with at least one sibling (with negative history of varicella disease/vaccination) at home, or
✓. attending day care center, or
✓. attending childminders, i.e. someone taking care of several children, or
✓. who are in contact for at least once a week with other children without a known positive history of varicella disease/vaccination, while playing in close physical contact for more than 5 minutes.

What they're measuring

Phase A: Number of Subjects With Confirmed Varicella Case

Timeframe: From 42 days post dose 2 until the end of Phase A

Trial details

NCT IDNCT00226499

SponsorGlaxoSmithKline

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-10-12

Results submitted2017-06-15

View on ClinicalTrials.gov More Varicella trials